[The efficacy of taktivin in patients with viral myocarditis and dilated cardiomyopathy].
The aim of the present research was to study the efficacy of the immunomodulating agent T-activin in patients with viral myocarditis and dilated cardiomyopathy (DCMP). The data obtained indicate that under the influence of the general therapy with T-activin cellular immunity manifested positive changes and the patients with viral myocarditis and DCMP felt better.
Kipshidze
N N
NN
Dzhaparidze
M M
MM
Dzidziguri
L M
LM
Rachvelishvili
N B
NB
Dateshidze
M N
MN
Demetrashvili
M F
MF
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000917:Antibody Formation / Q000187:drug effects / Q000276:immunology; D002311:Cardiomyopathy, Dilated / Q000188:drug therapy* / Q000276:immunology; D003384:Coxsackievirus Infections / Q000188:drug therapy* / Q000276:immunology; D004341:Drug Evaluation; D029822:Enterovirus B, Human; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009205:Myocarditis / Q000188:drug therapy* / Q000276:immunology; D010455:Peptides / Q000627:therapeutic use*; D013949:Thymus Extracts / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D010455:Peptides; D013949:Thymus Extracts; C036191:T-activin
Effektivnost' taktivina u bol'nykh virusnym miokarditom i dilatatsionnoĭ kardiomiopatieĭ.